Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma.
Mondaza-Hernandez JL, Hindi N, Fernandez-Serra A, Ramos R, Gonzalez-Cámpora R, Gómez-Mateo MC, Martinez-Trufero J, Lavernia J, Lopez-Pousa A, Laínez N, Martinez-Garcia J, Valverde C, Vaz-Salgado MÁ, Garcia-Plaza G, Marin-Borrero I, Carrillo-Garcia J, Martin-Ruiz M, Romero P, Gutierrez A, López-Guerrero JA, Moura DS, Martin-Broto J. Mondaza-Hernandez JL, et al. Among authors: vaz salgado ma. Ther Adv Med Oncol. 2024 Nov 4;16:17588359241293951. doi: 10.1177/17588359241293951. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39502403 Free PMC article.
SEOM-GEINO clinical guidelines for grade 2 gliomas (2023).
Vaz-Salgado MÁ, García BC, Pérez IF, Munárriz BJ, Domarco PS, González AH, Villar MV, Caro RL, Delgado MLV, Sánchez JMS. Vaz-Salgado MÁ, et al. Clin Transl Oncol. 2024 Nov;26(11):2856-2865. doi: 10.1007/s12094-024-03456-x. Epub 2024 Apr 25. Clin Transl Oncol. 2024. PMID: 38662171 Free PMC article.
Recurrent Glioblastoma: A Review of the Treatment Options.
Vaz-Salgado MA, Villamayor M, Albarrán V, Alía V, Sotoca P, Chamorro J, Rosero D, Barrill AM, Martín M, Fernandez E, Gutierrez JA, Rojas-Medina LM, Ley L. Vaz-Salgado MA, et al. Cancers (Basel). 2023 Aug 26;15(17):4279. doi: 10.3390/cancers15174279. Cancers (Basel). 2023. PMID: 37686553 Free PMC article. Review.
Prognostic value of circulating endothelial cells in glioblastoma patients: a pilot study.
Vaz Salgado MA, Earl J, Berrocal VR, Arrieta FS, Gomez A, Sepulveda-Sanchez JM, Perez-Nuñez Á, de la Fuente EC, Lourido D, Villamayor M, Pian H, Muriel A, Rossi E, Zamarchi R, Carrato A, Ley L. Vaz Salgado MA, et al. Future Sci OA. 2022 May 24;8(5):FSO796. doi: 10.2144/fsoa-2022-0008. eCollection 2022 Mar. Future Sci OA. 2022. PMID: 35662744 Free PMC article.
A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin.
Moura DS, Peña-Chilet M, Cordero Varela JA, Alvarez-Alegret R, Agra-Pujol C, Izquierdo F, Ramos R, Ortega-Medina L, Martin-Davila F, Castilla-Ramirez C, Hernandez-Leon CN, Romagosa C, Vaz Salgado MA, Lavernia J, Bagué S, Mayodormo-Aranda E, Vicioso L, Hernández Barceló JE, Rubio-Casadevall J, de Juan A, Fiaño-Valverde MC, Hindi N, Lopez-Alvarez M, Lacerenza S, Dopazo J, Gutierrez A, Alvarez R, Valverde C, Martinez-Trufero J, Martín-Broto J. Moura DS, et al. Among authors: vaz salgado ma. Mol Oncol. 2021 Dec;15(12):3691-3705. doi: 10.1002/1878-0261.12996. Epub 2021 Jun 30. Mol Oncol. 2021. PMID: 33983674 Free PMC article.
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study.
Martínez-Trufero J, De Sande-González LM, Luna P, Martin-Broto J, Álvarez R, Marquina G, Diaz-Beveridge R, Poveda A, Cano JM, Cruz-Jurado J, López Pousa A, Vaz Salgado MA, Valverde-Morales CM, Sevilla I, Martínez-García J, Rubio-Casadevall J, De Juan A, Carrasco JA, Moura DS, Gurruchaga-Sotes I, Gutiérrez A. Martínez-Trufero J, et al. Among authors: vaz salgado ma. Cancers (Basel). 2021 Feb 14;13(4):792. doi: 10.3390/cancers13040792. Cancers (Basel). 2021. PMID: 33672857 Free PMC article.
Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO).
Sepúlveda-Sánchez JM, Gil-Gil M, Alonso-García M, Vaz Salgado MÁ, Vicente E, Mesía Barroso C, Rodríguez Sánchez Á, Durán G, De Las Peñas R, Muñoz-Langa J, Velasco G, Hernández-Laín A, Hilario A, Navarro Martín M, Benavides M, Oleaga L, Cantero Montenegro D, Ruano Y, Sánchez-Gómez P, Martín-Soberón MC, Morales-Llombart R, Pachón V, Pineda E. Sepúlveda-Sánchez JM, et al. Among authors: vaz salgado ma. Target Oncol. 2020 Oct;15(5):613-622. doi: 10.1007/s11523-020-00754-6. Target Oncol. 2020. PMID: 33025213 Clinical Trial.
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
Stacchiotti S, Ferrari S, Redondo A, Hindi N, Palmerini E, Vaz Salgado MA, Frezza AM, Casali PG, Gutierrez A, Lopez-Pousa A, Grignani G, Italiano A, LeCesne A, Dumont S, Blay JY, Penel N, Bernabeu D, de Alava E, Karanian M, Morosi C, Brich S, Dagrada GP, Vallacchi V, Castelli C, Brenca M, Racanelli D, Maestro R, Collini P, Cruz J, Martin-Broto J. Stacchiotti S, et al. Among authors: vaz salgado ma. Lancet Oncol. 2019 Sep;20(9):1252-1262. doi: 10.1016/S1470-2045(19)30319-5. Epub 2019 Jul 19. Lancet Oncol. 2019. PMID: 31331701 Clinical Trial.
15 results